| Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C Y Tanaka, N Nishida, M Sugiyama, M Kurosaki, K Matsuura, N Sakamoto, ... Nature genetics 41 (10), 1105-1109, 2009 | 2785 | 2009 |
| Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 H Yoshiji, S Nagoshi, T Akahane, Y Asaoka, Y Ueno, K Ogawa, ... Journal of gastroenterology 56 (7), 593-619, 2021 | 376 | 2021 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 373 | 2020 |
| Dietary habits and nutrient intake in non-alcoholic steatohepatitis K Toshimitsu, B Matsuura, I Ohkubo, T Niiya, S Furukawa, Y Hiasa, ... Nutrition 23 (1), 46-52, 2007 | 353 | 2007 |
| Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system AM Contreras, Y Hiasa, W He, A Terella, EV Schmidt, RT Chung Journal of virology 76 (17), 8505-8517, 2002 | 249 | 2002 |
| Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography—establishment of the method for measurement Y Koizumi, M Hirooka, Y Kisaka, I Konishi, M Abe, H Murakami, ... Radiology 258 (2), 610-617, 2011 | 236 | 2011 |
| Etiology of liver cirrhosis in Japan: a nationwide survey K Michitaka, S Nishiguchi, Y Aoyagi, Y Hiasa, Y Tokumoto, M Onji, ... Journal of gastroenterology 45, 86-94, 2010 | 208 | 2010 |
| Hepatitis C virus expression suppresses interferon signaling by degrading STAT1 W Lin, WH Choe, Y Hiasa, Y Kamegaya, JT Blackard, EV Schmidt, ... Gastroenterology 128 (4), 1034-1041, 2005 | 202 | 2005 |
| Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis A Hiraoka, T Kumada, K Tsuji, K Takaguchi, E Itobayashi, K Kariyama, ... Liver cancer 8 (2), 121-129, 2019 | 193 | 2019 |
| Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease M Abe, T Miyake, A Kuno, Y Imai, Y Sawai, K Hino, Y Hara, S Hige, ... Journal of gastroenterology 50, 776-784, 2015 | 184 | 2015 |
| Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan Society of Hepatology: a comparison with the liver damage and … A Hiraoka, T Kumada, M Kudo, M Hirooka, K Tsuji, E Itobayashi, ... Liver cancer 6 (3), 204-215, 2017 | 181 | 2017 |
| Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma F Tada, M Abe, M Hirooka, Y Ikeda, Y Hiasa, Y Lee, NC Jung, WB Lee, ... International journal of oncology 41 (5), 1601-1609, 2012 | 173 | 2012 |
| FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma T Arao, K Ueshima, K Matsumoto, T Nagai, H Kimura, S Hagiwara, ... Hepatology 57 (4), 1407-1415, 2013 | 171 | 2013 |
| Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean N Nishida, H Sawai, K Matsuura, M Sugiyama, SH Ahn, JY Park, S Hige, ... PloS one 7 (6), e39175, 2012 | 165 | 2012 |
| Real‐time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases H Ochi, M Hirooka, Y Koizumi, T Miyake, Y Tokumoto, Y Soga, F Tada, ... Hepatology 56 (4), 1271-1278, 2012 | 155 | 2012 |
| Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis A Hiraoka, K Michitaka, D Kiguchi, H Izumoto, H Ueki, M Kaneto, ... European journal of gastroenterology & hepatology 29 (12), 1416-1423, 2017 | 147 | 2017 |
| Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A K Matsuura, Y Tanaka, S Hige, G Yamada, Y Murawaki, M Komatsu, ... Journal of clinical microbiology 47 (5), 1476-1483, 2009 | 146 | 2009 |
| Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab T Sera, Y Hiasa, K Michitaka, I Konishi, K Matsuura, Y Tokumoto, ... Internal Medicine 45 (11), 721-724, 2006 | 145 | 2006 |
| Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis A Hiraoka, T Kumada, M Atsukawa, M Hirooka, K Tsuji, T Ishikawa, ... Cancer Medicine 8 (8), 3719-3728, 2019 | 139 | 2019 |
| Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites T Uehara, M Hirooka, K Ishida, A Hiraoka, T Kumagi, Y Kisaka, Y Hiasa, ... Journal of gastroenterology 42, 306-311, 2007 | 136 | 2007 |
